Paid Clinical Trials Birmingham

Discover 901 paid clinical trials in Birmingham, Alabama. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 901

Study to Evaluate the Efficacy and Safety of K-877-ER and CSG452 in Participants With NASH With Liver Fibrosis

Recruiting

PHASE2

Sponsor:

Kowa Research Institute, Inc.

Location:

Birmingham, Columbus, Marietta, Flowoodshow 42 more

Code:

NCT05327127

Conditions

NASH

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

K-877-ER

CSG452

Placebo

DIAN-TU Amyloid Removal Trial (ART) in Dominantly Inherited Alzheimer's Disease

Recruiting

PHASE3

Sponsor:

Washington University School of Medicine

Location:

Birmingham, Saint Louis, Indianapolis, Seattle

Code:

NCT06384573

Conditions

Alzheimer's Disease

Dementia

Alzheimer's Disease, Familial

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

lecanemab

Impact of Bromocriptine on Clinical Outcomes for Peripartum Cardiomyopathy

Recruiting

Sponsor:

Dennis M. McNamara, MD, MS

Location:

Birmingham, Atlanta, Nashville, Lexingtonshow 43 more

Code:

NCT05180773

Conditions

Peripartum Cardiomyopathy, Postpartum

Eligibility Criteria

Sex: Female

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Bromocriptine

Placebo

Guideline Directed Medical Therapy for Heart Failure (GDMT)

Rivaroxaban

Second Placebo

A Study of Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus (T2DM)

Recruiting

PHASE2

Sponsor:

Amgen

Location:

Birmingham, Decatur, Marrero, Fleming Islandshow 20 more

Code:

NCT06660173

Conditions

Type 2 Diabetes Mellitus (T2DM)

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Maridebart Cafraglutide

Placebo

Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis

Recruiting

PHASE3

Sponsor:

Sanofi

Location:

Birmingham, Cullman, Knoxville, Greershow 78 more

Code:

NCT06141473

Conditions

Multiple Sclerosis

Eligibility Criteria

Sex: All

Age: 18 - 55

Healthy Volunteers: Not accepted

Interventions

Frexalimab

Teriflunomide

Placebo infusion

Placebo tablet

MRI contrast-enhancing agents

Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of EP262 in Subjects With Chronic Spontaneous Urticaria

Recruiting

PHASE2

Sponsor:

Escient Pharmaceuticals, Inc

Location:

Birmingham, Destin, Asheville, Owensboroshow 32 more

Code:

NCT06077773

Conditions

Chronic Spontaneous Urticaria

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Oral EP262

Placebo

Comparison of Methods of Pulmonary Blood Flow Augmentation in Neonates: Shunt Versus Stent (The COMPASS Trial)

Recruiting

Sponsor:

Carelon Research

Location:

Birmingham, Atlanta, Memphis, Charlotteshow 20 more

Code:

NCT05268094

Conditions

Congenital Heart Disease in Children

Eligibility Criteria

Sex: All

Age: 1 - 30

Healthy Volunteers: Not accepted

Interventions

Ductal Arterial Stent

Systemic-to-Pulmonary Artery Shunt

Enlighten Study: The EV-ICD Post Approval Registry

Recruiting

Sponsor:

Medtronic

Location:

Birmingham, Nashville, Memphis, Panama Cityshow 47 more

Code:

NCT06048731

Conditions

Ventricular Arrhythmia

Tachycardia

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Interventions

Defibrillation using EV-ICD

National Collaborative to Improve Care of Children With Complex Congenital Heart Disease

Recruiting

Sponsor:

Children's Hospital Medical Center, Cincinnati

Location:

Birmingham, Atlanta, Nashville, Jacksonshow 53 more

Code:

NCT02852031

Conditions

Hypoplastic Left Heart Syndrome (HLHS)

Eligibility Criteria

Sex: All

Age: 0 - 15

Healthy Volunteers: Not accepted

Interventions

Collaborative Learning Network

Study of Carbetocin Nasal Spray for the Treatment of Hyperphagia in Prader-Willi Syndrome

Recruiting

PHASE3

Sponsor:

ACADIA Pharmaceuticals Inc.

Location:

Birmingham, Nashville, Saint Louis, Columbusshow 19 more

Code:

NCT06173531

Conditions

Hyperphagia in Prader-Willi Syndrome

Eligibility Criteria

Sex: All

Age: 5 - 30

Healthy Volunteers: Not accepted

Interventions

Carbetocin

Placebo